These days you can even raise a seed with no experimental data. That was extraordinarily unusual even well into the 2000s.
There are articles around discussing how in case of Alzheimer's it was impossible to get VC funding for immune ideas, even though they already had interesting evidence.
The same cabal was also blocking them.
I think you need to be an insider to realize how incredibly political most research in medicine is.
McKinsey separately reported that there has since been another boom in the biotech sector in the 2020s [1].
[0] https://www.science.org/content/blog-post/biotech-class-earl...
[1] https://www.mckinsey.com/industries/life-sciences/our-insigh...
Thanks, McKinsey, that's a great use of your consulting superpowers. Hey, was there a boom in artificial intelligence around 2015 as well? For $65,000 an hour, I'm sure you'll be happy to tell us.
Apparently VCs are clamping down on loose funding in the current climate, or thats not the case in biotech?